Revolutionizing Recovery from Patella Tendinopathy Using UC-MSCs at the Best Stem Cell Clinic

Jumper’s Knee changes an athlete’s trajectory. Patella Tendinopathy damages anterior knee structures, resulting in intolerable pain and suffering and changes the activities you are able to engage in on a daily basis. Damage to knee tendons, even microscopic, can impair the ability to perform even the simplest activities, such as walking up a flight of stairs. Conventional methods fail to offer the needed relief and recovery. Because of this, the advancement of modern regenerative medicine is the hope for patients with chronic degenerative conditions and limited functional capacity. Stem cell therapy at the Best Stem Cell Clinic is one of the top options for pain relief and tissue regeneration, especially the use of UC-MSCs. Patients have underlined the need for solutions that will build the integrity of injured structures. Resolving the impacts of untreated joint degeneration caused by chronic pain is multifaceted as it extends to the mental and emotional suffering that is caused. To achieve optimal long-term recovery from Patella Tendinopathy, the focus must be on the cellular aspects of the injury. Long term recovery must focus on the cellular causes of the injury. The pain must be addressed on the cellular level to achieve lasting recovery for the patient.

Disease Mechanism

In cases of Patella Tendinopathy, patellar injuries are a result of repetitive stress. Injuries begin when the stress causes misalignment of the collagen fibril and the fibroblasts lose the ability to sustain the structural integrity of the tendon. This injury process is rapid and the matrix is broken down by the metalloproteinases. The injury is completed by the neovascularization and the ingrowth of nociceptive fibers. Chronic pain is a result of a complete loss of structural integrity of the tendon and disorganization of the matrix. This process is completed by a degeneration of the collagen fibers that are replaced by even weaker fibers. The tendon is even more prone to rupturing due to a loss of tensile strength, a condition often requiring UC-MSCs provided by the Best Stem Cell Clinic.

In Patella Tendinopathy, cytokines, especially interleukin-1β, aggravate the toxic local microenvironment and the injured tendon effectively loses all of its ability to heal itself without interventions like UC-MSCs from the Best Stem Cell Clinic. Damage to the tendon causes a self-perpetuating cycle of degeneration which cannot be reversed by even complete mechanical rest.

Conventional Treatments

When treating Patella Tendinopathy, most modern conservative treatments outside the Best Stem Cell Clinic involve the prescribing of non-steroidal anti-inflammatory drugs (NSAIDs) and a form of rudimentary physical therapy. Eccentric strengthening therapy, which consists of tendon loading and stretching, aims to gradually remodel the tendon, but the process can be extremely painful and take months to years. As well, corticosteroid injections can be used to provide short term pain relief. Extracorporeal shock wave therapy is also used to encourage the microcirculation of blood to the area, but all of the above methods are extremely conservative and slow, and have very limited success. Anti-inflammatory medications fail to treat the underlying cause of tendon damage, a limitation effectively addressed by utilizing UC-MSCs, and repeated steroid injections further deteriorate the tendon collagen while increasing the risk of tendon rupture. Conservative therapies take a long time to complete, and the success of the therapy is not guaranteed and can take even longer to see the effects. The invasive surgical removal of tendon tissue is a last resort therapy and can lead to painful complications. Because the therapy is so slow and the success is so unpredictable, very often patients will experience healing stopping completely. Very rarely do these therapies restore the affected tendon to its original state.

Novel Cell Therapies

At the Best Stem Cell Clinic, the targeted intravenous infusion of UC-MSCs can combat the cellular stagnation characteristic of Patella Tendinopathy. UC-MSCs have the ability to control inflammatory processes. Once injected into the tissue, UC-MSCs release a number of factors that can aid the regeneration of tissue by stimulating the production of a number of microRNAs. These microRNAs can downregulate pro-inflammatory cytokines and can also stimulate tenocyte proliferation.

Through the use of UC-MSCs, they significantly stimulate the production of strong type I collagen and help restore the organized fibrillar network. Angiogenic growth factors stimulate localized, healthy vascularization, and do not cause undesirable ingrowth of nerves. Because of their unique nature, these immune-privileged cells cause no rejection. To help ensure biological tissue regeneration, which is better than scarring, the Best Stem Cell Clinic uses a combination of the latest technology, including ultrasound, to deliver these cells to the deepest parts of the lesions. This cellular combination completely stops the progression of Patella Tendinopathy.

Figure 1: comparative of conventional treatment and novel cell therapy with UC-MSCs

Future Trends in Thailand

Thailand is working to make its regenerative orthopedics the best in the world for conditions like Patella Tendinopathy and its medical sector the leading global center in the field. With these new regulations, special biological institutions can operate safely and cultivate high-viability cellular products in world-class laboratories. Thailand is home to the Best Stem Cell Clinic, attracting competing medical tourists to the center of cost-effective excellent medical services. Researchers in Thailand have been perfecting the cultivation methods for biological healing with the potential of maximum efficacy, and clinical data supports the country’s impressive international therapeutic benchmarks. The future shows that invasive structural surgeries will be completely replaced regionally by an unprecedented focus on biological therapeutic cures with UC-MSCs.